Reagents OPT 4 task order
Ended Awarded Last action
- Contract number
- W81K0224F0128
- Awardee
-
Diasorin Inc. UEI FGK2QR959BV5 Part of Diasorin S.P.A.
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $85,364
Award facts
- Opportunity
-
- Automated ID serology analyzer Pre-Solicitation · W81K0220Q0128 · Posted May 12, 2020
- Contract value 100% obligated
- $85,364.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- LEWIS MCCHORD, WA 98431, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $85,364 | |
| Original award | $0 |
About this award
The Defense Health Agency awarded a $85,364.46 delivery order to Diasorin Inc. for varicella zoster virus (VZV) immunoglobulin G (IgG) reagents under the "Reagents Opt 4 Task Order" contract. This delivery order, issued on October 1, 2024, reflects modifications to item numbers and quantities while adding FY25 funding, with performance concluding by September 30, 2025. The award is structured as a firm fixed-price delivery order with no socioeconomic set-aside designation. Performance will take place at Lewis-McChord, Washington, a major Department of Defense installation that houses medical facilities requiring diagnostic laboratory capabilities.
Diasorin Inc., a Minnesota-based subsidiary of Italian-owned Diasorin S.P.A., specializes in chemiluminescence immunoassay analyzers and diagnostic reagents for federal healthcare agencies. This delivery order is likely issued against one of Diasorin's existing indefinite delivery contracts with the Defense Health Agency, which the company maintains for LIAISON test kits and supplies valued at $540,000 through September 2030. Diasorin performs as the prime contractor without identified subcontractors and has established itself as a key supplier to the Defense Health Agency and broader federal healthcare system, providing comprehensive infectious disease diagnostic solutions across multiple federal agencies including the Department of Veterans Affairs, Centers for Disease Control and Prevention, and the National Institutes of Health.
Quick answers
Who was awarded contract W81K0224F0128?
W81K0224F0128 was awarded to Diasorin Inc. by Medical Command (Department of the Army) on October 1, 2024.
How much is contract W81K0224F0128 worth?
The government has obligated $85,364 on W81K0224F0128.
Which agency awarded contract W81K0224F0128?
Medical Command (Department of the Army) awarded W81K0224F0128, with funding from Defense Health Agency (Department of Defense).
Is contract W81K0224F0128 an order under another contract?
Yes. W81K0224F0128 is a delivery order under W81K0220D0019, an indefinite delivery contract.
Was contract W81K0224F0128 competed?
The extent of competition for W81K0224F0128 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award